Cross Infection: Clinical Trials

5 trials for Cross Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 withdrawn. 5 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Withdrawn 5
Phase 22Withdrawn 2

Follow Cross Infection: new trials by email Literature Review of Cross Infection trials Research Report on Cross Infection

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
Cefepime-taniborbactam, Meropenem - Ventilator-associated Pneumonia, Hospital-acquired Pneumonia
Phase 3WithdrawnVenatorx Pharmaceuticals, Inc.2025-06-012025-06-08
A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
Meropenem-Vaborbactam, Piperacillin/Tazobactam - Hospital-Acquired Bacterial Pneumonia, Ventilator-Associated Bacterial Pneumonia
Phase 3WithdrawnMelinta Therapeutics, Inc.2018-08-012019-01-11
Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria
Polymyxin B, Polymyxin B + Doripenem - Bacteremia, Healthcare-associated Pneumonia
Phase 2 / Phase 3WithdrawnTan Tock Seng Hospital2015-01-012019-10-09
Bronchoscopy vs. Clinical Pulmonary Infection Score Guided Approach in Suspected Ventilator-Associated Pneumonia (VAP)
Bronchoscopy, Clinical pulmonary infection score (CPIS) - Ventilator Associated Pneumonia
Phase 3WithdrawnMayo Clinic2007-01-012023-09-26
Comparison Study of High Frequency Percussive Ventilation With Conventional Ventilation
High Frequency Percussive Ventilation - Respiratory Distress Syndrome, Adult, Pneumonia
Phase 2 / Phase 3WithdrawnUniversity of Texas Southwestern Medical Center2006-01-012019-01-17

Narrower conditions

Pneumonia, Ventilator-Associated (5)  ·  Healthcare-Associated Pneumonia (3)  ·  Acute Lung Injury (1)  ·  Bacteremia (1)  ·  Pneumonia (1)  ·  Pneumonia, Bacterial (1)  ·  Respiratory Distress Syndrome (1)

Broader conditions

Disease Attributes (5)  ·  Iatrogenic Disease (5)  ·  Infections (5)  ·  Lung Diseases (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Respiratory Tract Diseases (5)  ·  Respiratory Tract Infections (5)  ·  Pneumonia (4)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Healthcare-Associated Pneumonia (2)  ·  Inflammation (1)  ·  Lung Injury (1)

Interventions

Bronchoscopy (1)  ·  Doripenem (1)  ·  Meropenem (1)  ·  Piperacillin, Tazobactam Drug Combination (1)  ·  Polymyxin B (1)  ·  meropenem and vaborbactam (1)

Sponsors

Mayo Clinic (1)  ·  Melinta Therapeutics, Inc. (1)  ·  Tan Tock Seng Hospital (1)  ·  University of Texas Southwestern Medical Center (1)  ·  Venatorx Pharmaceuticals, Inc. (1)

Countries

Singapore (1)  ·  United States (1)

Top investigators

Bekele Afessa, MD (1)  ·  David Lye, MBBS, FRACP (1)  ·  Randall Friese, MD (1)